HWG Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-34,934
Closed -$3.33M 59
2025
Q4
$3.33M Sell
34,934
-23,641
-40% -$2.32M 0.81% 20
2025
Q3
$5.72M Sell
58,575
-1,528
-3% -$158K 1.45% 21
2025
Q2
$6.46M Buy
60,103
+8,343
+16% +$844K 1.89% 17
2025
Q1
$5.22M Buy
51,760
+41,105
+386% +$4.14M 2.33% 16
2024
Q4
$952K Buy
10,655
+4,207
+65% +$370K 0.31% 35
2024
Q3
$540K Buy
6,448
+186
+3% +$14.7K 0.19% 42
2024
Q2
$482K Buy
+6,262
New +$458K 0.18% 29
2023
Q4
$362K Sell
6,268
-127
-2% -$6.78K 0.16% 42
2023
Q3
$338K Sell
6,395
-155
-2% -$8.13K 0.18% 43
2023
Q2
$354K Buy
+6,550
New +$342K 0.16% 50

Other funds holding BSX

HWG Holdings's BSX Position: Q1 2026 in Review

HWG Holdings sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 34,934 shares — an estimated $3.33M sold.

HWG Holdings first reported a position in BSX in Q2 2023 and held it in 10 quarters. The position peaked at $6.46M in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • HWG Holdings reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • HWG Holdings sold 34,934 Boston Scientific shares in Q1 2026, an estimated $3.33M.
  • HWG Holdings first reported a position in Boston Scientific in Q2 2023 and held it in 10 quarters.
  • HWG Holdings's Boston Scientific position peaked at $6.46M in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on HWG Holdings's 13F filing for Q1 2026, filed 6 May 2026.